Söndag 11 Maj | 19:46:12 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-08-28 18:50 Kvartalsrapport 2025-Q2
2025-06-06 N/A X-dag ordinarie utdelning CRNA 0.00 NOK
2025-06-05 N/A Årsstämma
2025-04-10 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-19 - Årsstämma
2024-06-06 - X-dag ordinarie utdelning CRNA 0.00 NOK
2024-04-25 - Bokslutskommuniké 2023
2023-10-04 - Split CRNA 30:1
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-22 - Årsstämma
2023-04-21 - X-dag ordinarie utdelning CRNA 0.00 NOK
2023-03-09 - Extra Bolagsstämma 2023
2023-02-16 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-18 - Kvartalsrapport 2022-Q2
2022-05-12 - Kvartalsrapport 2022-Q1
2022-04-20 - Årsstämma
2022-04-07 - X-dag ordinarie utdelning CRNA 0.00 NOK
2022-02-17 - Bokslutskommuniké 2021
2021-11-25 - Extra Bolagsstämma 2021
2021-11-04 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-18 - X-dag ordinarie utdelning CRNA 0.00 NOK
2021-03-17 - Årsstämma
2021-02-18 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-20 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-04-30 - X-dag ordinarie utdelning CRNA 0.00 NOK
2020-04-29 - Årsstämma
2020-03-11 - Bokslutskommuniké 2019
2019-11-07 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-09 - Kvartalsrapport 2019-Q1
2019-04-10 - X-dag ordinarie utdelning CRNA 0.00 NOK
2019-04-09 - Årsstämma
2019-02-14 - Bokslutskommuniké 2018
2018-11-01 - Kvartalsrapport 2018-Q3
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-03 - Kvartalsrapport 2018-Q1
2018-04-12 - X-dag ordinarie utdelning CRNA 0.00 NOK
2018-04-11 - Årsstämma
2018-02-15 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-04-25 - Kvartalsrapport 2017-Q1
2017-04-05 - Årsstämma
2017-02-16 - Bokslutskommuniké 2016
2016-11-17 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-12 - Kvartalsrapport 2016-Q1
2016-04-14 - X-dag ordinarie utdelning CRNA 0.00 NOK
2016-04-13 - Årsstämma
2015-06-23 - X-dag ordinarie utdelning CRNA 0.00 NOK
2015-06-22 - Årsstämma

Beskrivning

LandNorge
ListaOslo Bors
SektorHälsovård
IndustriBioteknik
Circio Holding är ett läkemedelsbolag. Bolaget specialistkompetens återfinns inom riktad immunterapi som används vid behandling av cancerpatienter. Bolagets verksamhet består av forskning och utveckling och läkemedlen säljs idag under separata varumärken. Ett flertal partnerskap på marknaden har ingåtts för att stärka samarbetet inom utvecklingen av ny immunterapi. Bolaget grundades 2010 och har sitt huvudkontor i Lysaker.
2023-09-06 16:40:47

Circio Holding ASA is calling for an EGM on 27 September 2023 to vote on the following items:

1. The amendment to the Investment Agreement with Atlas
2. A 30:1 reverse stock split to increase the trading price to above NOK 1 (with necessary capital increase)
3. A reduction of the share capital of 2.5 NOK per share

Reference is made to the announcement by Circio Holding ASA on 24 August 2023 that certain changes to the Investment Agreement with Atlas Special Opportunities, LLC ("Atlas") will be presented for a shareholder vote in an extraordinary general meeting (EGM) during September 2023. Due to difficult market conditions and reduced trading volume in Circio shares it has been challenging to utilize the financing facility as foreseen, and risk has increased for both Circio and Atlas. An amendment to the Investment Agreement relating to trading limitations and fees has been negotiated and agreed with Atlas, which the board and management of Circio recommend for shareholders to approve to ensure necessary flexibility for both parties to effectively manage the financing structure.

Further, to comply with minimum share price obligations for companies listed on the Oslo Stock Exchange, pursuant to which the market value for listed shares shall not be lower than NOK 1 for a period of longer than six months, the board of directors proposes that the Circio Holding ASA shares are consolidated in the ratio of 30:1 (reverse split), whereby 30 existing shares, each with a nominal value of NOK 0.1, shall be consolidated to one share with nominal value NOK 3. Following the share consolidation, it is proposed that the Company's share capital shall be reduced by NOK 2.5 to NOK 0.5 per share, and that the reduction amount is used to cover a portion of the Company's accumulated losses, as reflected in the balance sheet per 31 December 2022. 

The proposed amendment to the Investment Agreement, as well as the corresponding amendments to the bond terms entered into with Nordic Trustee AS, and the proposed share consolidation and share capital decrease, are subject to approval by the general meeting. The Company's board of directors has resolved to summon an extraordinary general meeting ("EGM") to be held at the Company's offices at Lysaker on 27 September 2023 at 09:00 CET. The EGM notice is attached to this announcement.

The proposed amendments to the Agreement have been published on the Company's website: Extraordinary General Meeting 2023 (https://www.circio.com/en/extraordinary-general-meeting-september-2023/) (Governance / General meetings) and is also attached to this announcement.

Attachements:

EGM notice Circio Holding ASA - with English appendix.pdf (https://mb.cision.com/Public/17093/3830823/b426ca545f903664.pdf)

EGM notice Circio Holding ASA - with Norwegian appendix.pdf (https://mb.cision.com/Public/17093/3830823/9490b1a2ac022d92.pdf)

Circio investment and subscription - Amendment agreement.pdf (https://mb.cision.com/Public/17093/3830823/94c7b7b3a279748c.pdf)